scPharmaceuticals Inc.
NASDAQ:SCPH
2.44 (USD) • At close May 9, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||
| Nettowinst
| -85.148 | -54.81 | -36.838 | -28.034 | -32.209 | -32.996 | -29.443 | -23.817 | -24.377 | -10.518 |
| Afschrijvingen & Amortisatie
| 0.02 | 0.626 | 0.468 | 0.438 | 0.399 | 0.364 | 0.332 | 0.167 | 0.005 | 0.004 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0.03 | 0.002 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 5.442 | 4.856 | 2.838 | 2.366 | 2 | 1.449 | 2.135 | 0.947 | 0.876 | 0.379 |
| Verandering in Werkkapitaal
| 0 | -6.321 | -0.35 | -2.599 | 1.448 | 0.354 | -2.21 | -0.177 | 1.529 | 0.889 |
| Vorderingen
| -7.289 | -4.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0.1 | -7.609 | -1.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0.592 | 5.556 | 1.767 | -2.365 | 1.212 | 0.965 | -1.377 | 0.951 | 1.743 | 0.974 |
| Overig Werkkapitaal
| 0 | 0.221 | -0.887 | -0.234 | 0.236 | -0.611 | -0.833 | -1.128 | -0.214 | -0.085 |
| Overige Niet-Contante Posten
| 9.148 | -3.595 | -0.695 | 0.678 | 0.639 | 0.385 | 0.374 | 0.198 | 6.512 | -0.394 |
| Kasstroom uit Operationele Activiteiten
| -70.538 | -59.244 | -34.577 | -27.151 | -27.693 | -30.442 | -28.812 | -22.682 | -15.455 | -9.64 |
| Investeringsactiviteiten: | ||||||||||
| Investeringen in Materiële Vaste Activa
| -0.021 | -0.04 | -0.021 | -0.009 | 0 | 0 | 0 | -0.194 | -0.009 | -0.017 |
| Netto Overnames
| 0 | 0 | 45.838 | -32.139 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | -50.595 | -67.538 | -9.011 | -72.16 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 29.32 | 70.6 | 21.7 | 41.15 | 38.7 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | -45.838 | 32.139 | -33.46 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 29.299 | 19.965 | -45.859 | 32.13 | -33.46 | 0 | 0 | -0.194 | -0.009 | -0.017 |
| Financieringsactiviteiten: | ||||||||||
| Schuldaflossingen
| -3.228 | 0 | 29.801 | -2.5 | 0 | 9.555 | -0.062 | 9.273 | 12.6 | 0 |
| Uitgifte van Gewone Aandelen
| 53.547 | 14.038 | 47.765 | 0.051 | 60.576 | 3.973 | 0 | 92.71 | 40.639 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | -0.081 | -0.164 | 0 | -0.004 | -0.003 | 0 | -0.009 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 19.761 | 0.812 | -0.337 | -0.081 | -0.228 | 0.06 | 0.058 | 0.094 | 40.573 | 8.026 |
| Kasstroom uit Financieringsactiviteiten
| 70.08 | 14.85 | 77.229 | -2.53 | 60.348 | 13.588 | -0.008 | 102.074 | 53.173 | 8.017 |
| Overige Informatie: | ||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 28.841 | -24.429 | -3.207 | 2.449 | -0.805 | -16.854 | -28.82 | 79.198 | 37.709 | -1.64 |
| Kaspositie aan het Einde van de Periode
| 75.655 | 46.814 | 71.243 | 74.45 | 72.001 | 72.806 | 89.66 | 118.48 | 39.282 | 1.573 |